
Florida broker pleads guilty in $135M ACA fraud scheme; for celiac patients, fiber may not be enough; FDA clears at-home cervical cancer test – Morning Medical Update
Key Takeaways
- Federal enforcement actions include APSF’s guilty plea with $27.6M restitution and AssuredPartners’ $107M FCA settlement, following street-marketing tactics and application falsification to maximize ACA subsidies.
- Loss of Medicaid eligibility after improper ACA enrollment created downstream clinical harm, with some patients unable to afford antiretrovirals, MOUD, and psychotropic therapies.
The top news stories in medicine today.
Florida insurance broker to pay over $135M for fraudulent ACA enrollment scheme
APSF and its parent company, AssuredPartners, targeted homeless and low-income individuals, enrolling them in subsidized plans they did not qualify for.
A Florida insurance brokerage and its former parent company have agreed to pay a combined $135 million to resolve allegations that they
For celiac patients, fiber alone may not be enough
People with celiac disease often lack the gut bacteria needed to actually process the fiber they eat.
People with celiac disease may not benefit from high-fiber diets or supplements the way other patients do. That’s not because they aren’t eating enough fiber, but because they lack the gut bacteria needed to break it down, according to a study published in
Researchers at
The researchers also found that fiber type matters: inulin, found in bananas, garlic, and onions, promoted intestinal healing in preclinical models, while a corn-based resistant starch did not. Future treatment, the authors suggest, may need to combine dietary changes with targeted probiotics to restore the missing bacteria.
FDA clears at-home cervical cancer screening kit
The self-collection kit is expected to be available nationwide by prescription in coming months.
The Food and Drug Administration (FDA) has cleared an at-home cervical cancer screening kit from lab equipment manufacturer Waters, allowing patients to collect a sample at home and mail it to a laboratory, with results sent to their physician. The kit is designed to detect all high-risk types of human papillomavirus (HPV), which the World Health Organization estimates causes about 95% of cervical cancers when left untreated. Waters said roughly 60% of cervical cancers occur in people who are not screened or are screened less frequently than recommended. Nationwide availability by prescription is anticipated in the coming months.






